We are live on ! Find out more
PALI icon

Palisade Bio

5 hedge funds and large institutions have $1.83M invested in Palisade Bio in 2017 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 0 increasing their positions, reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

5,160% more call options, than puts

Call options by funds: $263K | Put options by funds: $5K

30% more capital invested

Capital invested by funds: $1.41M → $1.83M (+$422K)

0% less ownership

Funds ownership: 0%0% (-0%)

17% less funds holding

Funds holding: 65 (-1)

50% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 2

Holders
5
Holders Change
-1
Holders Change %
-16.67%
% of All Funds
0.11%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
1
Increased
Reduced
Closed
2
Calls
$263K
Puts
$5K
Net Calls
+$258K
Net Calls Change
+$246K

Top Buyers

Rank Fund Capital Flow
1
William Blair & Company
William Blair & Company
Illinois
+$130K

PALI Hedge Fund Activity: Q4 2017 in Review

5 of the 4,409 institutional investors tracked by Wall St. Rank reported a position in Palisade Bio (PALI) for Q4 2017, worth a combined $1.83M — up 30% from $1.41M a quarter earlier.

Sellers outnumbered buyers: 2 funds closed out of PALI and 1 opened new positions — a net loss of 1 holder — while 0 trimmed existing stakes and 0 added.

The largest buyer was William Blair & Company, opening a new position worth an estimated $130K. The largest seller was Virtu Financial, exiting entirely with an estimated $80K sold.

  • 5 institutional investors held Palisade Bio (PALI) as of Q4 2017, down from 6 in Q3 2017.
  • Funds reported $1.83M of Palisade Bio stock for Q4 2017, up 30% quarter-over-quarter.
  • 1 fund opened new Palisade Bio positions in Q4 2017 and 2 closed out, a net change of -1 holder.
  • The largest Palisade Bio buyer in Q4 2017 was William Blair & Company, an estimated $130K added.
  • The largest Palisade Bio seller in Q4 2017 was Virtu Financial, an estimated $80K sold.

Based on aggregated 13F filings for Q4 2017.